Risk Based Monitoring

Delivering Precision, Compliance, and Efficiency through Our Risk-Based Monitoring Solutions

Charting success with Risk Based Monitoring Excellence!

Clinical trial studies entail several complex elements that must be firmly monitored to guarantee the participant safety, uphold study protocol, and comply with regulatory requirements.
Efficient monitoring is essential in the clinical trial for safeguarding the well-being of the trial participants and ensuring the integrity of high-quality studies. Sponsors must bear the responsibility of overseeing trials to uphold the rights, welfare and safety of human subjects as well as the reliability of the trial relevant data.
Regulatory agencies like FDA and EMA mandate sponsors to monitor clinical investigations, encouraging them to develop risk-based monitoring plans that manage human subject risks and data quality. This approach focuses on preventing or managing significant risks to data integrity, human subject protection, and trial credibility, leveraging modern clinical trial methodologies.

FDA and EMA defined risk-based monitoring (RBM) as a crucial part of clinical trial management strategies, that involves a blend of centralized and on-site procedures to ensure human subject welfare and trial ethics. RBM aims to identify, assess, manage, communicate, and review risks throughout the trial’s duration, ensuring safety, and integrity, protection of subjects’ rights, data quality, and trial credibility.

Clients need monitoring services to ensure high quality standards across the clinical trials that they are in adherence with regulatory recommendation. We, Zenovel are able to assist by providing expertise and global resources necessary for effective monitoring

We, Zenovel offermultiple customized service packages tailored to meet specific requirements of each study, consideringfactors like design, risks, and client preferences. We prioritize understanding clients’ needs and aim to provide a balance between cost-effectiveness and quality assurance, ensuring a comprehensive solution for each study.

Healthy Participants (Bioequivalence Studies/Phase-I)

(Phase-II/III/IV), we assist in listed process

Based on EMA Guidance

Our skilled monitors evaluate your procedures and develop the best strategy tailored to your specific needs, often employing one or more of the RBM tactics outlined below.
Our skilled monitors evaluate your proZenovel offers comprehensive support for your next clinical trial, maximizing the potential of risk-based monitoring. With our site services, we provide a complete range of services, from protocol development to data dissemination. Experience a more efficient and patient-centric trial journey with us.cedures and develop the best strategy tailored to your specific needs, often employing one or more of the RBM tactics outlined below.
Zenovel offers comprehensive support for your next clinical trial, maximizing the potential of risk-based monitoring. With our site services, we provide a complete range of services, from protocol development to data dissemination. Experience a more efficient and patient-centric trial journey with us.
To discover how we can expedite your clinical trial process from start to finish, SCHEDULE A CONSULTATION with our team today
Reach out to us for any inquiries or support needs.

Blogs and news

Our Latest Article